Detalles de la búsqueda
1.
Impact of acute coronary syndrome on clinical outcomes after revascularization with the dual-therapy CD34 antibody-covered sirolimus-eluting Combo stent and the sirolimus-eluting Orsiro stent.
Catheter Cardiovasc Interv
; 101(1): 13-21, 2023 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36378691
2.
Randomized Clinical Comparison of the Dual-Therapy CD34 Antibody-Covered Sirolimus-Eluting Combo Stent With the Sirolimus-Eluting Orsiro Stent in Patients Treated With Percutaneous Coronary Intervention: The SORT OUT X Trial.
Circulation
; 143(22): 2155-2165, 2021 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-33823606
3.
Impact of diabetes on clinical outcomes after revascularization with the dual therapy CD34 antibody-covered sirolimus-eluting Combo stent and the sirolimus-eluting Orsiro stent.
Catheter Cardiovasc Interv
; 99(7): 1965-1975, 2022 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-35384254
4.
Randomized clinical comparison of the dual-therapy CD34 antibody-covered sirolimus-eluting Combo stent with the sirolimus-eluting Orsiro stent in patients treated with percutaneous coronary intervention: Rationale and study design of the Scandinavian Organization for Randomized Trials with Clinical Outcome (SORT OUT) X trial.
Am Heart J
; 202: 49-53, 2018 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-29807307
5.
Dual-therapy CD34 antibody-covered sirolimus-eluting COMBO stents versus sirolimus-eluting Orsiro stents in patients treated with percutaneous coronary intervention: the three-year outcomes of the SORT OUT X randomised clinical trial.
EuroIntervention
; 19(8): 676-683, 2023 Oct 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-37584207
6.
Acute Treatment and 5-Year Follow-up of Longitudinal Deformation of a Bioresorbable Scaffold.
J Invasive Cardiol
; 33(4): E318-E319, 2021 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-33794484
Resultados
1 -
6
de 6
1
Próxima >
>>